The administration of guanidine in amyotrophic lateral sclerosis

Neurology

Volumn 24, Issue 8, 1974, Pages 721-728

  Norris, Forbes H ^a   Calanchini, Philip R ^a   Fallat, Robert J ^a   Panchari, Sandra ^a   Jewett, Barbara ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANIDINE;

ADVERSE DRUG REACTION; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; BONE MARROW DEPRESSION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG THERAPY; EUPHORIA; FASCICULATION; HUMAN; HYALINE MEMBRANE DISEASE; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SEBORRHEA; SKIN; SLURRED SPEECH; STOMACH; THERAPY; VERTIGO;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GUANIDINES; HUMANS; MALE; MIDDLE AGED; MUSCLES; NAUSEA; PARALYSIS; RESPIRATORY FUNCTION TESTS; VERTIGO; VITAL CAPACITY;

EID: 0016251677     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.24.8.721     Document Type: Article

References (27)

1. Norris FH: Prognosis in amyotrophic lateral sclerosis. Trans Am Neurol Assoc 96:290-291, 1971
2. Engel WK, et al: Metabolic studies and therapeutic trials in amyotrophic lateral sclerosis. In Norris FH, Kurland LT (Editors): Motor Neuron Diseases. New York, Grune & Stratton, Inc., 1969, pp 199-213
3. Gergens F, Baumann E: Über das Verhalten des Guanidin, Dicyan- diamidin, und Cynamid in Organismus. Pflüg Arch Physiol 12:205-214, 1876
4. Putzeys F, Swaen A: Action physiologique du sulfate de guanidine. Pflüegers Arch 12:597-634, 1876
5. Fastier FN: Structure-activity relationships of amidine derivatives. Pharmacol Rev 14:37-90, 1962
6. Minot AS, Dodd K, Riven SS: Use of guanidine hydrochloride in treatment of myasthenia gravis. JAMA 113:553-559, 1939
7. Minot AS: A comparison of the effect of calcium and of atropine and scopolamine on the plasma loss and on the general symptoms of guanidine intoxication. J Pharmacol Exp Ther 65:243-252, 1939
8. Davidoff F: Guanidine derivatives in medicine. N Engl J Med 289:141-146, 1973
9. Brown JC, Johns RJ: Clinical and physiological studies of the effect of guanidine on patients with myasthenia gravis. Johns Hopkins Med J 124:1-8, 1969
10. Otsuka M, Endo M: The effect of guanidine on neuromuscular transmission. J Pharmacol Exp Ther 128:273-282, 1960
11. Lambert EH, Rooke ED: Myasthenic state and lung cancer. In (Lord) Brain, Norris FH (Editors): The Remote Effects of Cancer on the Nervous System. New York, Grune & Stratton, Inc., 1965, pp 67-80
12. Elmqvist D, Lambert EH: Detailed analyses of neuromuscular function in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 43:689-691, 1968
13. Cherington M, Ryan DW: Treatment of botulism with guanidine. N Engl J Med 282:195-197, 1970
14. Rightsel WA, Dice JR, McAlpine RJ, et al: Antiviral effect of guanidine. Science 134:558-559, 1961
15. Crowther D, Melnick JL: Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology 15:65-74, 1961
16. Oh SJ, Kim KW: Guanidine hydrochloride in the Eatoπ-Lambert syndrome. Neurology (Minneap) 23:1084-1090, 1973
17. Lenman JAR: Clinical and experimental study of the effects of exercise on motor weakness in neurological disease. J Neurol Neurosurg Psychiatry 22:182-194, 1959
18. Campbell AMG, Williams ER, Barltrop D: Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry 33:877-885, 1970
19. Currier RD, Haerer AF: Amyotrophic lateral sclerosis and metallic toxins. Arch Environ Health 17:712-719, 1968
20. Bass MP, Fallat RJ, Norris FH: Pulmonary function evaluation in amyotrophic lateral sclerosis. In preparation.
21. Norris FH, Eaton JM, Mielke CH: Depression of bone marrow by guanidine. Arch Neurol 30:184-185, 1974
22. Nakano K, Tyler HR: Cardiovascular complications of guanidine hydrochloride. (Letter) Ann Intern Med 77:658, 1972
23. Norris FH, Fallat RJ, Calanchini PR: Increased paralysis induced by guanidine in motor neuron disease. Neurology (Minneap) 24:135-137, 1974
24. Major RH: The possible relationship between guanidine and high blood pressure. Am J Med Sci 170:228-232, 1925
25. Minot AS, Cutler JT: Increase in guanidine-like substance in acute liver injury and eclampsia. Proc Soc Exp Biol Med 26:607-611, 1929
26. Oldstone MBA, et al: Immunoglobulin deposits in amyotrophic lateral sclerosis. Trans Am Neurol Assoc 98:181-182, 1973
27. Norris FH: Discussion. Trans Am Neurol Assoc 97:22, 1972